Summary
In a significant market movement during August 2025, EnsiliTech was the subject of a vc funding. The transaction achieved a gross valuation of £4,500,000. Leading the round was chANGELS, Eos Advisory, Empirical Ventures, Penn Park Capital, The Fink Family Office, Calculus Capital, Qantx, HERmesa.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
chANGELS
Lead Investor / Acquirer
Eos Advisory
Lead Investor / Acquirer
Empirical Ventures
Lead Investor / Acquirer
Penn Park Capital
Lead Investor / Acquirer
The Fink Family Office
Lead Investor / Acquirer
Calculus Capital
Lead Investor / Acquirer
Qantx
Lead Investor / Acquirer
HERmesa
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in